• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Difficult to Advance (2920)
Patient Problem Hematoma (1884)
Event Date 09/07/2022
Event Type  Injury  
Manufacturer Narrative
The device won't be returned for analysis.Upon evaluation of the failure analysis of the event reported, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported that a cardiac hematoma occurred.A left atrial appendage (laa) closure procedure was attempted using a 27mm watchman laa closure device with delivery system (wds) and a watchman fxd curve access system (was).A versacross connect laac access solution kit was selected for use during the transseptal puncture (tsp).The first and second attempts of radiofrequency (rf) crossing to complete a transseptal puncture (tsp) were unsuccessful.After the second attempt the rf needle slid superiorly.The third tsp was successful however the wire prolapsed and would not cross the septum.The wire was manipulated, and the septal cross was completed.Placement of the closure device was attempted requiring four device recaptures.It was determined the positioning difficulties resulted from the high location of the tsp.The was, wds, and closure device were all removed from the patient and also the sales representative confirmed that a tsp device was baylis versacross connect.After when a transesophageal echocardiogram (tee) was performed a hematoma was present in the left atrium adjacent to the laa on the posterior aspect of the heart.The laa closure procedure was discontinued.The patient was discharged four days post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on
CA  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17591883
MDR Text Key321618518
Report Number2124215-2023-44505
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age82 YR
Patient SexMale
Patient RaceWhite
-
-